By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

TG Therapeutics, Inc. 

787 Seventh Avenue
48th Floor
New York  New York  10019  U.S.A.
Phone: 212-554-4484 Fax: 212-554-4531


SEARCH JOBS


Industry
Pharmaceutical






Company News
TG Therapeutics, Inc. (MHA) Announces Fourth Quarter And Year-End 2014 Financial Results And Business Update 3/12/2015 7:42:53 AM
TG Therapeutics, Inc. (MHA) To Host Conference Call On Fourth Quarter And Year-End 2014 Financial Results And Business Update 3/10/2015 7:49:46 AM
TG Therapeutics, Inc. (MHA) To Present At The 27th Annual ROTH Conference 3/6/2015 8:01:57 AM
TG Therapeutics, Inc. (MHA) Enters Into A Global Collaboration With Checkpoint Therapeutics To Develop And Commercialize Novel Immuno-Oncology Targeted Antibodies 3/4/2015 7:12:48 AM
TG Therapeutics, Inc. (MHA) To Present At The Cowen and Company 35th Annual Health Care Conference 3/2/2015 7:49:02 AM
TG Therapeutics, Inc. (MHA) To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/4/2015 7:52:50 AM
TG Therapeutics, Inc. (MHA) To Provide An Update On Its Clinical Programs And Corporate Goals For 2015 At The 33rd Annual J.P. Morgan Healthcare Conference 1/15/2015 7:11:52 AM
TG Therapeutics, Inc. (MHA) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/8/2015 12:29:22 PM
TG Therapeutics, Inc. (MHA) Announces Appointment Of Kenneth Hoberman To Board Of Directors 12/17/2014 7:45:45 AM
TG Therapeutics, Inc. (MHA) Release: Preliminary Data From Ongoing Phase I/II Dose Escalation Study Of TG-1101 (Ublituximab) In Combination With TGR-1202 In Heavily Pre-Treated Relapsed/Refractory B-Cell Malignancies Demonstrates Encouraging Clinical Activity And Safety 12/9/2014 10:49:31 AM
12345678910...
//-->